RecruitingEarly Phase 1NCT05597098

Investigation of the Distinct Mechanisms Involved in Inflammatory Resolution Between Healthy Men and Women

Investigation of the Distinct Mechanisms Involved in Inflammatory Resolution Between Healthy Men and Women: RESOLVE-SEX


Sponsor

Queen Mary University of London

Enrollment

34 participants

Start Date

Dec 12, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Important differences exist between sexes in incidence, disease patterns and outcomes in coronary artery disease that is not well understood. It is likely that key differences in the underlying biological mechanism, in particular in inflammatory responses, play a part in underpinning these differences. Previous evidence demonstrates that healthy females appear to be more adept at resolving inflammation compared to healthy males. Since inflammation is thought to be a key initiating phenomenon in coronary artery disease the investigators will examine the differences in inflammatory resolution between the sexes in healthy volunteers.


Eligibility

Min Age: 18 YearsMax Age: 45 Years

Inclusion Criteria3

  • Healthy male and female volunteers
  • Aged 18-45
  • Volunteers who are willing to sign the consent form

Exclusion Criteria7

  • Healthy subjects unwilling to consent
  • Pregnant, or any possibility that a subject may be pregnant unless in the latter case a pregnancy test is performed with a negative result
  • Current breast feeding
  • History of any serious illnesses, including recent infections or trauma
  • Subjects taking systemic medication (other than the oral contraceptive pill)
  • Subjects with recent (2 weeks) or current antibiotic use
  • Subjects with any history of a blood-borne infectious disease such as Hepatitis B or C virus, or HIV

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCantharidin

0.1% cantharidin solution in acetone from 0.7% stock solution of cantharone is prepared and applied immediately. 10 μl of cantharidin per disc.


Locations(1)

The William Harvey Research Institute

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05597098


Related Trials